107 related articles for article (PubMed ID: 29042396)
1. Differentiated thyroid cancer: millions spent with no tangible gain?
Furuya-Kanamori L; Sedrakyan A; Onitilo AA; Bagheri N; Glasziou P; Doi SAR
Endocr Relat Cancer; 2018 Jan; 25(1):51-57. PubMed ID: 29042396
[TBL] [Abstract][Full Text] [Related]
2. Initial attributable cost and economic burden of clinically-relevant differentiated thyroid cancer: A health care service provider perspective.
Lang BH; Wong CK; Chan CT
Eur J Surg Oncol; 2015 Jun; 41(6):758-65. PubMed ID: 25680952
[TBL] [Abstract][Full Text] [Related]
3. Annual financial impact of thyroidectomies for nodular thyroid disease in China.
Liu XY; Zhu LJ; Cui D; Wang ZX; Chen HH; Duan Y; Shen MP; Zhang ZH; Wang XD; Chen JW; Alexander EK; Yang T
Asian Pac J Cancer Prev; 2014; 15(14):5921-6. PubMed ID: 25081723
[TBL] [Abstract][Full Text] [Related]
4. A cost-minimization analysis comparing total thyroidectomy alone and total thyroidectomy with prophylactic central neck dissection in clinically nodal-negative papillary thyroid carcinoma.
Lang BH; Wong CK
Ann Surg Oncol; 2014 Feb; 21(2):416-25. PubMed ID: 23982258
[TBL] [Abstract][Full Text] [Related]
5. Determinants of long-term quality of life in patients with differentiated thyroid carcinoma - a population-based cohort study in Sweden.
Hedman C; Djärv T; Strang P; Lundgren CI
Acta Oncol; 2016; 55(3):365-9. PubMed ID: 26541091
[TBL] [Abstract][Full Text] [Related]
6. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
7. Recurrent disease in juvenile differentiated thyroid carcinoma: prognostic factors, treatments, and outcomes.
Mihailovic J; Nikoletic K; Srbovan D
J Nucl Med; 2014 May; 55(5):710-7. PubMed ID: 24722527
[TBL] [Abstract][Full Text] [Related]
8. Improving postoperative recurrence rates for carcinoma of the thyroid gland.
McHenry C; Jarosz H; Lawrence AM; Paloyan E
Surg Gynecol Obstet; 1989 Nov; 169(5):429-34. PubMed ID: 2814754
[TBL] [Abstract][Full Text] [Related]
9. Health-Related Quality of Life After Diagnosis and Treatment of Differentiated Thyroid Cancer and Association With Type of Surgical Treatment.
Nickel B; Tan T; Cvejic E; Baade P; McLeod DSA; Pandeya N; Youl P; McCaffery K; Jordan S
JAMA Otolaryngol Head Neck Surg; 2019 Mar; 145(3):231-238. PubMed ID: 30653212
[TBL] [Abstract][Full Text] [Related]
10. Ongoing risk stratification for differentiated thyroid cancer (DTC) - stimulated serum thyroglobulin (Tg) before radioiodine (RAI) ablation, the most potent risk factor of cancer recurrence in M0 patients.
Krajewska J; Jarząb M; Czarniecka A; Roskosz J; Kukulska A; Handkiewicz-Junak D; Puch Z; Wygoda Z; Paliczka-Cieślik E; Kropińska A; Gubała E; Jurecka-Lubieniecka B; Jarząb B
Endokrynol Pol; 2016; 67(1):2-11. PubMed ID: 26884109
[TBL] [Abstract][Full Text] [Related]
11. Overdiagnosis and overtreatment of thyroid cancer: A population-based temporal trend study.
Jegerlehner S; Bulliard JL; Aujesky D; Rodondi N; Germann S; Konzelmann I; Chiolero A;
PLoS One; 2017; 12(6):e0179387. PubMed ID: 28614405
[TBL] [Abstract][Full Text] [Related]
12. Role of hemithyroidectomy in differentiated thyroid cancer.
Gibelli B; Dionisio R; Ansarin M
Curr Opin Otolaryngol Head Neck Surg; 2015 Apr; 23(2):99-106. PubMed ID: 25692624
[TBL] [Abstract][Full Text] [Related]
13. [The impact of the extent and time of operation on the survival in patients with differentiated thyroid carcinoma (DTC)].
Czarniecka A; Jarzab M; Krajewska J; Sacher A; Półtorak S; Włoch J
Endokrynol Pol; 2006; 57(4):347-55. PubMed ID: 17006835
[TBL] [Abstract][Full Text] [Related]
14. High default rate in thyroid cancer management in Ibadan, Nigeria: a need for health insurance.
Adedapo KS; Fadiji IO; Orunmuyi AT; Ejeh JE; Osifo BO
Afr J Med Med Sci; 2012 Dec; 41 Suppl():105-9. PubMed ID: 23678644
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma.
Frasoldati A; Pesenti M; Gallo M; Caroggio A; Salvo D; Valcavi R
Cancer; 2003 Jan; 97(1):90-6. PubMed ID: 12491509
[TBL] [Abstract][Full Text] [Related]
16. Differentiated thyroid cancer in a Swedish county--long-term results and quality of life.
Malterling RR; Andersson RE; Falkmer S; Falkmer U; Niléhn E; Järhult J
Acta Oncol; 2010 May; 49(4):454-9. PubMed ID: 20092427
[TBL] [Abstract][Full Text] [Related]
17. Pediatric Differentiated Thyroid Cancer: When to Perform Conservative and Radical Surgery.
Spinelli C; Rossi L; Piscioneri J; Strambi S; Antonelli A; Ferrari A; Massimino M; Miccoli P
Curr Pediatr Rev; 2016; 12(4):247-252. PubMed ID: 27745544
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the costs of active surveillance and immediate surgery in the management of low-risk papillary microcarcinoma of the thyroid.
Oda H; Miyauchi A; Ito Y; Sasai H; Masuoka H; Yabuta T; Fukushima M; Higashiyama T; Kihara M; Kobayashi K; Miya A
Endocr J; 2017 Jan; 64(1):59-64. PubMed ID: 27667647
[TBL] [Abstract][Full Text] [Related]
19. [Relapse of differentiated thyroid carcinoma in low-risk patients].
Krajewska J; Czarniecka A; Jarzab M; Kukulska A; Hankiewicz-Junak D; Hasse-Lazar K; Gubała E; Puch Z; Paliczka E; Roskosz J
Endokrynol Pol; 2006; 57(4):386-91. PubMed ID: 17006841
[TBL] [Abstract][Full Text] [Related]
20. [Two decades of progress in the diagnosis and treatment of differentiated thyroid cancer].
Benbassat C; Hirsch D; Robenshtok E; Bachar G
Harefuah; 2014 Aug; 153(8):482-6, 496. PubMed ID: 25286642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
